antipyrine has been researched along with ergotamine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Baringer, JR; Raskin, NH | 1 |
ARCANGELI, P; GALLETTI, R | 1 |
MIRECKI, GB | 1 |
1 review(s) available for antipyrine and ergotamine
Article | Year |
---|---|
Approach to the patient with migraine.
Topics: Analgesics, Non-Narcotic; Antipyrine; Chloral Hydrate; Drug Combinations; Drug Therapy, Combination; Ergotamine; Female; Humans; Menopause; Methylamines; Middle Aged; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Vasodilator Agents; Verapamil | 1996 |
6 other study(ies) available for antipyrine and ergotamine
Article | Year |
---|---|
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
[Effect of pyramidone, ergotamine and codeine on pain sensitivity threshold and on erythralgic reactivity].
Topics: Aminopyrine; Antipyrine; Codeine; Ergot Alkaloids; Ergotamine; Humans; Oxytocics; Pain; Pain Threshold | 1953 |
[FURTHER EXPERIENCES WITH VERTEBRAN IN ORTHOPEDIC PRACTICE].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Atropine; Back Pain; Brachial Plexus Neuritis; Caffeine; Drug Therapy; Ergotamine; Humans; Hydrocortisone; Joint Diseases; Osteochondritis; Polymyalgia Rheumatica; Prednisolone; Prednisone; Procaine; Reflex Sympathetic Dystrophy; Spinal Osteophytosis; Spondylitis; Spondylitis, Ankylosing; Strychnine | 1965 |